Y.D. More Investments’s AstraZeneca AZN Stock Holding History

Y.D. More Investments’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-79	Closed	-$35	–	475
2025 Q3	$35	Buy	+79	New	+$12K	﹤0.01%	466
2024 Q1	–	Sell	-450	Closed	-$60.6K	–	334
2023 Q4	$60.6K	Hold	450	–	–	0.01%	227
2023 Q3	$60.9K	Sell	450 -205	-31%	-$28K	0.01%	226
2023 Q2	$93.7K	Sell	655 -1,150	-64%	-$169K	0.02%	180
2023 Q1	$251K	Sell	1,805 -1,600	-47%	-$215K	0.06%	123
2022 Q4	$464K	Buy	+3,405	New	+$427K	0.11%	110

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Y.D. More Investments's AZN Position: Q4 2025 in Review

Y.D. More Investments sold out of AstraZeneca (AZN) in Q4 2025, closing a stake of 79 shares — an estimated $35 sold.

Y.D. More Investments first reported a position in AZN in Q4 2022 and held it in 6 quarters. The position peaked at $464K in Q4 2022. 1,406 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

Y.D. More Investments reported no remaining AstraZeneca position as of Q4 2025 after selling out during the quarter.
Y.D. More Investments sold 79 AstraZeneca shares in Q4 2025, an estimated $35.
Y.D. More Investments first reported a position in AstraZeneca in Q4 2022 and held it in 6 quarters.
Y.D. More Investments's AstraZeneca position peaked at $464K in Q4 2022.
1,406 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on Y.D. More Investments's 13F filing for Q4 2025, filed 21 Jan 2026.